<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mbd5-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mbd5-dis</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">MBD5</italic> Haploinsufficiency</title>
        <alt-title alt-title-type="alt-title">Synonyms: 2q23.1 Microdeletion Syndrome, <italic toggle="yes">MBD5</italic>-Associated Neurodevelopmental Disorders (MAND)</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mullegama</surname>
            <given-names>Sureni V</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Pathology and Laboratory Medicine<break/>University of California at Los Angeles<break/>David Geffen School of Medicine<break/>Los Angeles, California</aff>
          <email>svmullegama@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mendoza-Londono</surname>
            <given-names>Roberto</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Associate Professor of P&#x000e6;diatrics and Molecular Genetics, University of Toronto<break/>The Hospital for Sick Children<break/>Division of Clinical and Metabolic Genetics<break/>Toronto, Ontario, Canada</aff>
          <email>roberto.mendoza@sickkids.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Elsea</surname>
            <given-names>Sarah H</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Department of Molecular and Human Genetics<break/>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>elsea@bcm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>27</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ftdp-17" document-type="chapter"><italic toggle="yes">MAPT</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="thctd" document-type="chapter">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</related-object>
      <abstract id="mbd5-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency is a neurodevelopmental disorder characterized by global developmental delay/intellectual disability (ID), severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in about 80%; onset is usually around age two years. Sleep disturbances, present in about 80% can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (60%).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Most commonly the diagnosis of <italic toggle="yes">MBD5</italic> haploinsufficiency is established in a proband by detection of one of the following alterations on molecular genetic testing:</p>
          <list list-type="bullet">
            <list-item>
              <p>Deletion of 2q23.1 that encompasses all or part of <italic toggle="yes">MBD5</italic> (~90% of affected individuals)</p>
            </list-item>
            <list-item>
              <p>Intragenic deletion involving one or more exons of <italic toggle="yes">MBD5</italic> (~5%)</p>
            </list-item>
            <list-item>
              <p>A heterozygous pathogenic sequence variant in <italic toggle="yes">MBD5</italic> (~5%).</p>
            </list-item>
          </list>
          <p>Rarely, an apparently balanced complex chromosome rearrangement of the 2q23.1 region involving <italic toggle="yes">MBD5</italic> is causative.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A multidisciplinary approach that typically includes specialists in clinical genetics, neurology, child development, behavioral therapy, nutrition/feeding, speech and language therapy, and occupational and physical therapy is recommended. Infants benefit from enrollment in an early-intervention program, and school-age children benefit from an individualized educational program. Speech therapy (including nonverbal methods of communication) should be introduced early. Seizures, behavior problems, and sleep disturbances are treated in a routine manner.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic neurodevelopmental and behavioral evaluations to assist in the management of cognitive and behavioral problems.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency is inherited in an autosomal dominant manner. Typically, deletion of 2q23.1 is <italic toggle="yes">de novo</italic>; in some instances, an <italic toggle="yes">MBD5</italic> pathogenic deletion or <italic toggle="yes">MBD5</italic> sequence variant is inherited from a parent who is mildly affected. Rarely, parent-to-child transmission of an unbalanced derivative chromosome involving the 2q23.1 region occurs. Once the genetic alteration resulting in <italic toggle="yes">MBD5</italic> haploinsufficiency has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mbd5-dis.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mbd5-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency, a neurodevelopmental disorder, <bold>should be suspected</bold> in individuals with the following findings [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2016.1376">Mullegama &#x00026; Elsea 2016</xref>]:</p>
          <p>
            <bold>Neurologic</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Intellectual disability (ID), usually moderate to severe</p>
            </list-item>
            <list-item>
              <p>Motor delays</p>
            </list-item>
            <list-item>
              <p>Severe speech impairment</p>
            </list-item>
            <list-item>
              <p>Seizures</p>
            </list-item>
            <list-item>
              <p>Sleep disturbance</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Feeding difficulties, often related to hypotonia</p>
            </list-item>
          </list>
          <p>
            <bold>Behavior</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Short attention span</p>
            </list-item>
            <list-item>
              <p>Autistic-like behaviors which include gaze avoidance, inattention, and repetitive behaviors</p>
            </list-item>
            <list-item>
              <p>Self-injury and/or aggressive behaviors</p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">MBD5</italic> haploinsufficiency <bold>is established</bold> in a proband with one of the following (see <xref ref-type="table" rid="mbd5-dis.T.molecular_genetic_testing_use">Table 1</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p>Deletion of 2q23.1 that encompasses all or part of <italic toggle="yes">MBD5</italic> (~90% of affected individuals)</p>
            </list-item>
            <list-item>
              <p>Intragenic deletion involving one or more exons of <italic toggle="yes">MBD5</italic> (~5%)</p>
            </list-item>
            <list-item>
              <p>A heterozygous pathogenic sequence variant in <italic toggle="yes">MBD5</italic> (~5%)</p>
            </list-item>
            <list-item>
              <p>Rarely, an apparently balanced complex chromosome rearrangement of the 2q23.1 region involving <italic toggle="yes">MBD5</italic></p>
            </list-item>
          </list>
          <p>Molecular genetic testing approaches can include a combination of <bold>genomic testing</bold> (chromosomal microarray analysis [CMA] or more comprehensive genomic testing) and <bold>gene-targeted</bold>
<bold>testing</bold> (multi-gene panel or single-gene testing).</p>
          <p>Gene-targeted testing requires the clinician to hypothesize which gene(s) are likely involved, whereas genomic testing may not. Because many inherited disorders share the phenotypic findings of ID, seizures, and behavior problems, most children with <italic toggle="yes">MBD5</italic> haploinsufficiency are diagnosed by the following recommended testing (CMA and/or a multi-gene panel) or testing to be considered (comprehensive genomic testing sequencing).</p>
          <sec id="mbd5-dis.Recommended_FirstTier_Testing">
            <title>Recommended First-Tier Testing</title>
            <p><bold>Chromosomal microarray analysis (CMA</bold>) should be the first genetic test as about 90% of <italic toggle="yes">MBD5</italic> haploinsufficiency is caused by large, non-recurrent deletions, which cannot be detected by sequence analysis of <italic toggle="yes">MBD5</italic>.</p>
            <p>Note: The phenotype of significantly larger or smaller deletions within this region may be clinically distinct from <italic toggle="yes">MBD5</italic> haploinsufficiency (see <xref ref-type="sec" rid="mbd5-dis.Genetically_Related_Disorders">Genetically Related Disorders</xref>).</p>
          </sec>
          <sec id="mbd5-dis.Options_for_SecondTier_Testing">
            <title>Options for Second-Tier Testing</title>
            <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">MBD5</italic> and other genes of interest (see <xref ref-type="sec" rid="mbd5-dis.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            <p><bold>More comprehensive genomic testing</bold> (when available) including whole-exome sequencing (WES) or whole-genome sequencing (WGS) maybe considered if the phenotype alone is insufficient to support gene-targeted testing). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <p>Note: Single-gene testing (sequence analysis of <italic toggle="yes">MBD5</italic> followed by gene-targeted deletion/duplication analysis* (if no pathogenic variant is found) may be considered in individuals with features that are highly suggestive of <italic toggle="yes">MBD5</italic> haploinsufficiency. However, because many of these features overlap with those of many other genetic disorders with ID, seizures, and behavior issues, a multi-gene panel or whole-exome sequencing is typically used in lieu of single-gene testing.</p>
            <p>*Gene-targeted deletion/duplication analysis should include evaluation of exon 1, which is non-coding, since deletions that include only exon 1 result in <italic toggle="yes">MBD5</italic> haploinsufficiency.</p>
            <table-wrap id="mbd5-dis.T.molecular_genetic_testing_use" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in <italic toggle="yes">MBD5</italic> Haploinsufficiency</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MBD5</italic>
                    </td>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CMA&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~90%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~5%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~5%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mbd5-dis.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mbd5-dis" object-id="mbd5-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mbd5-dis.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="mbd5-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="mbd5-dis.TF.1.3">
                  <label>3. </label>
                  <p>CMA identifies deletion of 2q23.1 (<italic toggle="yes">de novo</italic> terminal and interstitial deletions)</p>
                </fn>
                <fn id="mbd5-dis.TF.1.4">
                  <label>4. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="mbd5-dis.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="mbd5-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mbd5-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency is a neurodevelopmental disorder that comprises global developmental delay/intellectual disability (ID), severe speech impairment, seizures, sleep disturbances, and behavioral problems with autistic features [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</xref>].</p>
          <p><bold>Developmental delays,</bold> evident in all children with <italic toggle="yes">MBD5</italic> haploinsufficiency within the first year of life, include delays in gross motor and fine motor development, receptive and expressive language development, and acquisition of social skills. Children typically acquire new skills, without evidence of psychomotor regression.</p>
          <p>Motor delays with poor coordination and broad-based/ataxic gait are seen in more than 70% of individuals. The average age of walking is two to three years [<xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p>Language development is severely impaired [<xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>]. Most reported children lack speech entirely [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>] or have single words or short (2- to 3-word) phrases [<xref ref-type="bibr" rid="mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</xref>] or (2- to 6-word) sentences [<xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p><bold>Seizures</bold> occur in more than 80% of children [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p>Onset of seizures is usually around age two years [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.williams.2010.436">Williams et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.chung.2011.424">Chung et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.shichiji.2013.850">Shichiji et al 2013</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p>Although seizure types have not been well characterized, typically only one seizure type is observed in an individual. Seizure types have included absence spells and generalized tonic-clonic, atonic, sleep-related, and startle-induced atonic seizures [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.williams.2010.436">Williams et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.chung.2011.424">Chung et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p>In the few instances in which EEG studies have been performed, patterns were nonspecific; however, a few individuals were reported to have focal spikes and spike-wave complexes [<xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
          <p><bold>Sleep disturbances</bold>, present in about 80% of affected children, include frequent nighttime waking, apparent night terrors in the early part of sleep, and waking in the early hours of the morning [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.williams.2010.436">Williams et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.chung.2011.424">Chung et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2014.57">Mullegama et al 2014</xref>].</p>
          <p>Many exhibit excessive daytime sleepiness [<xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2015b.781">Mullegama et al 2015b</xref>].</p>
          <p><bold>Behavior problems</bold> (observed in <italic toggle="yes">MBD5</italic> haploinsufficiency and other forms of syndromic autism) [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>] include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Short attention span and autistic-like behaviors (gaze avoidance, inattention, and repetitive behaviors) [<xref ref-type="bibr" rid="mbd5-dis.REF.tan.2014.975">Tan et al 2014</xref>] and stereotypic and repetitive behaviors (e.g., teeth grinding, chewing of the hands, and repetitive hand movements) are seen in more than 80% of affected individuals.</p>
            </list-item>
            <list-item>
              <p>Self-injury and aggression are seen in more than 60% of individuals.</p>
            </list-item>
            <list-item>
              <p>Other behaviors mentioned in approximately 9% of reported individuals include anxiety, hyperactivity, inappropriate happy demeanor, and social withdrawal.</p>
            </list-item>
          </list>
          <p><bold>Other findings</bold> [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Feeding difficulties</bold> and constipation, likely related to hypotonia, in more than 90% of infants</p>
            </list-item>
            <list-item>
              <p><bold>Mild dysmorphic features</bold> (seen in the majority of affected individuals) that may include broad forehead, thick/highly arched eyebrows, outer ear abnormalities (e.g., forward-facing large earlobes, protruding ears, cupped ears), short nose, depressed or wide nasal bridge, downturned corners of the mouth, everted vermilion of the lower lip, tented and thin vermilion of the upper lip</p>
            </list-item>
            <list-item>
              <p><bold>Skeletal abnormalities</bold> (observed in 65 individuals with <italic toggle="yes">MBD5</italic> haploinsufficiency) including: small hands and feet (~75%), fifth finger clinodactyly (~70%), generalized brachydactyly (~41%), short fifth digit of the hands and feet (40%), and sandal gap (~33%) [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>]</p>
              <p>Other musculoskeletal abnormalities mentioned in at least two affected individuals each are hip dysplasia, joint laxity, and scoliosis.</p>
            </list-item>
            <list-item>
              <p><bold>Cardiovascular abnormalities</bold> (seen in ~10%) including atrial septal defect, ventricular septal defect, and pulmonary valve stenosis</p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Current data show that <italic toggle="yes">MBD5</italic> haploinsufficiency is due to decreased <italic toggle="yes">MBD5</italic> dosage, which can result from large or small deletions involving <italic toggle="yes">MBD5</italic> or pathogenic sequence variants in <italic toggle="yes">MBD5</italic>. Although no genotype-phenotype correlations distinguish individuals with pathogenic sequence variants from those with deletions, individuals with larger deletions involving multiple genes may exhibit a more severe phenotype.</p>
        </sec>
        <sec id="mbd5-dis.Penetrance">
          <title>Penetrance</title>
          <p>Clinical features of <italic toggle="yes">MBD5</italic> haploinsufficiency are apparent in all individuals with <italic toggle="yes">de novo</italic> inactivation of one <italic toggle="yes">MBD5</italic> allele; however, both phenotypic heterogeneity and variable expressivity are observed.</p>
          <p>In some instances, probands have inherited the variant (small <italic toggle="yes">MBD5</italic> deletion or duplication or missense variant) from a mildly affected parent in an autosomal dominant manner, suggesting that incomplete penetrance and/or variable expressivity may be associated with this condition [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
        </sec>
        <sec id="mbd5-dis.Nomenclature">
          <title>Nomenclature</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency was first recognized when overlapping deletions of 2q23.1 were identified in individuals with intellectual disability (ID) and &#x0201c;pseudo-Angelman&#x0201d; phenotypes using array comparative genomic hybridization (array-CGH) [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>].</p>
          <p>This disorder was initially called 2q23.1 deletion syndrome; however, delineation of the smallest region of overlap among individuals with a 2q23.1 deletion confirmed that haploinsufficiency of <italic toggle="yes">MBD5</italic> is responsible for the disorder. In addition, subsequent identification of heterozygous pathogenic sequence variants in <italic toggle="yes">MBD5</italic> further supports the use of the term <italic toggle="yes">MBD5</italic> haploinsufficiency.</p>
          <p>OMIM uses an outdated term for MBD5 haploinsufficiency: mental retardation, autosomal dominant 1; MRD1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/156200">OMIM</ext-link>).</p>
        </sec>
        <sec id="mbd5-dis.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">MBD5</italic> haploinsufficiency is not known. Because many individuals with <italic toggle="yes">MBD5</italic> haploinsufficiency may go undiagnosed, the prevalence may be greater than observed to date.</p>
          <p>Approximately 1% of 4808 individuals (from 3 cohorts) ascertained for autism spectrum disorder were found to have <italic toggle="yes">MBD5</italic> haploinsufficiency when assessed for CNVs involving <italic toggle="yes">MBD5</italic> and for <italic toggle="yes">MBD5</italic> sequence variants not present in controls [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>].</p>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency has been identified worldwide and is present in all ethnic groups.</p>
        </sec>
      </sec>
      <sec id="mbd5-dis.Genetically_Related_Disorders">
        <title>Genetically Related Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with either deletion of the 2q23.1 region involving <italic toggle="yes">MBD5</italic> or heterozygous pathogenic variants in <italic toggle="yes">MBD5.</italic></p>
        <p>Non-recurrent duplications involving <italic toggle="yes">MBD5</italic> have been described in 23 individuals to date [<xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2014.57">Mullegama et al 2014</xref>]. The clinical phenotype is similar to but perhaps less severe than that of <italic toggle="yes">MBD5</italic> haploinsufficiency and includes mild dysmorphic features, ID, developmental delay, motor delay, severe language impairment, infantile hypotonia, sleep disturbances, behavioral problems, and autistic-like features.</p>
      </sec>
      <sec id="mbd5-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of <italic toggle="yes">MBD5</italic> haploinsufficiency is broad due to the variable spectrum and presence of relatively common abnormal phenotypes that occur in affected individuals (e.g., developmental delay, learning problems, neuropsychiatric disorders). All manifestations of the <italic toggle="yes">MBD5</italic> haploinsufficiency can also be seen in individuals with other genomic disorders.</p>
        <p>Significant similarity in phenotypic features is observed between <italic toggle="yes">MBD5</italic> haploinsufficiency and other neurodevelopmental syndromes. Specific disorders to consider in the differential diagnosis of <italic toggle="yes">MBD5</italic> haploinsufficiency include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith-Magenis syndrome</related-object> (SMS)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="angelman" document-type="chapter">Angelman syndrome</related-object> (AS)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="pitt-hopkins" document-type="chapter">Pitt-Hopkins syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter">Rett syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter">Fragile X syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="kleefstra" document-type="chapter">Kleefstra syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Koolen-De Vries syndrome link <related-object link-type="booklink" source-id="gene" document-id="mdel17q21_31" document-type="chapter"><italic toggle="yes">KANSL1-</italic>related intellectual disability syndrome</related-object></p>
          </list-item>
        </list>
      </sec>
      <sec id="mbd5-dis.Management">
        <title>Management</title>
        <sec id="mbd5-dis.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">MBD5</italic> haploinsufficiency, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical and neurologic examination</p>
            </list-item>
            <list-item>
              <p>Developmental assessment including assessment by a physical therapist and/or occupational therapist</p>
            </list-item>
            <list-item>
              <p>Speech evaluation including feeding evaluation and nutrition consultation as needed</p>
            </list-item>
            <list-item>
              <p>Hearing assessment (as part of the routine evaluation of children with speech delay)</p>
            </list-item>
            <list-item>
              <p>EEG if seizures are suspected</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation</p>
            </list-item>
            <list-item>
              <p>Sleep history</p>
            </list-item>
            <list-item>
              <p>Behavioral assessment</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A multidisciplinary approach to manage the features and specific issues identified is recommended. Specialists in the following fields are often involved: clinical genetics, neurology, child development, behavioral therapy, nutrition/feeding, speech and language therapy, and occupational and physical therapy.</p>
          <p>
            <bold>Neurologic</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Infants benefit from enrollment in an early-intervention program.</p>
            </list-item>
            <list-item>
              <p>School-age children benefit from an individualized educational program.</p>
            </list-item>
            <list-item>
              <p>Speech therapy with early introduction of nonverbal methods of communication (e.g., sign language and computer-assisted technologies) is appropriate given the high risk for poor or absent speech.</p>
            </list-item>
            <list-item>
              <p>Antiepileptic drugs (AEDs) such as valproate, clonazepam, zonisamide and clobazam appear to be effective in reducing the incidence of seizures [<xref ref-type="bibr" rid="mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.williams.2010.436">Williams et al 2010</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.chung.2011.424">Chung et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>]. No information is available on response to specific AEDs.</p>
            </list-item>
          </list>
          <p>
            <bold>Behavior</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Routine management of behavioral issues associated with severe intellectual disability and/or autism spectrum disorder is indicated.</p>
            </list-item>
            <list-item>
              <p>Management of sleep disturbance through a combined approach of targeted sleep hygiene (to develop firm daily schedules) and use of daily medications such as melatonin, clonidine, and trazadone may be considered [<xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2015b.781">Mullegama et al 2015b</xref>].</p>
            </list-item>
            <list-item>
              <p>Routine management is necessary for constipation (which can affect behavior).</p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate surveillance includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Periodic neurodevelopmental and behavioral evaluations to assist in the management of cognitive and behavioral problems;</p>
            </list-item>
            <list-item>
              <p>Periodic reevaluations by a clinical geneticist to provide new recommendations and information regarding <italic toggle="yes">MBD5</italic> haploinsufficiency.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mbd5-dis.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mbd5-dis.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="mbd5-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mbd5-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">MBD5</italic> haploinsufficiency is inherited in an autosomal dominant manner. Almost all cases reported to date have resulted from one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>A <italic toggle="yes">de novo</italic> 2q23.1 deletion involving part or all of <italic toggle="yes">MBD5</italic> (~90% of probands)</p>
            </list-item>
            <list-item>
              <p>An intragenic <italic toggle="yes">MBD5</italic> deletion (~5% of probands)</p>
            </list-item>
            <list-item>
              <p>An <italic toggle="yes">MBD5</italic> pathogenic variant (~5% of probands)</p>
            </list-item>
            <list-item>
              <p>Rarely, an apparently balanced complex chromosome rearrangement of the 2q23.1 region involving <italic toggle="yes">MBD5</italic></p>
            </list-item>
          </list>
        </sec>
        <sec id="mbd5-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ninety percent of individuals diagnosed with <italic toggle="yes">MBD5</italic> haploinsufficiency have the disorder as the result of a <italic toggle="yes">de novo</italic> 2q23.1 deletion.</p>
            </list-item>
            <list-item>
              <p>Some individuals diagnosed with <italic toggle="yes">MBD5</italic> haploinsufficiency have a mildly affected parent from whom they have inherited a partial or complete deletion of <italic toggle="yes">MBD5</italic> or an <italic toggle="yes">MBD5</italic> pathogenic sequence variant [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>For the accurate assessment of recurrence risk, evaluation of the parents by molecular genetic testing that will detect the genetic alteration identified in the proband or an apparently balanced translocation of the 2q23.1 region is recommended.</p>
            </list-item>
            <list-item>
              <p>If the genetic alteration found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent (a possibility that should be communicated to families).</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with <italic toggle="yes">MBD5</italic> haploinsufficiency may appear to be negative because of failure to recognize the disorder in affected family members with a milder phenotype (i.e., variable expressivity) or reduced penetrance. Therefore, an apparently negative family history must be confirmed with molecular genetic testing of the parents of the proband [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>Risk to sibs is low, as 90% of individuals diagnosed with <italic toggle="yes">MBD5</italic> haploinsufficiency have the disorder as the result of a <italic toggle="yes">de novo</italic> 2q23.1 deletion.</p>
            </list-item>
            <list-item>
              <p>If one of the parents has the 2q23.1 deletion, <italic toggle="yes">MBD5</italic> deletion, or <italic toggle="yes">MBD5</italic> pathogenic variant identified in the proband, the risk to each sib of inheriting the genetic alteration is 50%. Several multi-generation families with <italic toggle="yes">MBD5</italic> haploinsufficiency have been reported [<xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</xref>, <xref ref-type="bibr" rid="mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>If the 2q23.1 deletion, <italic toggle="yes">MBD5</italic> deletion, or <italic toggle="yes">MBD5</italic> pathogenic variant identified in the proband is not identified in one of the parents, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">MBD5</italic> haploinsufficiency is at a 50% risk of inheriting the genetic alteration.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has a 2q23.1 deletion, <italic toggle="yes">MBD5</italic> deletion, or <italic toggle="yes">MBD5</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="mbd5-dis.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of having a child with <italic toggle="yes">MBD5</italic> haploinsufficiency.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mbd5-dis.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the genetic alteration resulting in <italic toggle="yes">MBD5</italic> haploinsufficiency has been identified in an affected family member, prenatal testing for a pregnancy at increased risk for <italic toggle="yes">MBD5</italic> haploinsufficiency and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="mbd5-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mbd5-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>Prior to the identification of <italic toggle="yes">MBD5</italic> as the gene involved in 2q23.1 deletion syndrome, little was known about <italic toggle="yes">MBD5</italic>.</p>
        <p><bold>Gene structure.</bold> The primary <italic toggle="yes">MBD5</italic> transcript (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018328.4">NM_018328.4</ext-link>) contains 15 exons. Exons 1-5 are the non-coding exons, followed by ten coding exons. The translation start site is located in exon 6. See <related-object source-id="gene" document-id="mbd5-dis" object-id="mbd5-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold> for a detailed summary of gene and protein information.</p>
        <p>A second isoform containing eight exons (4 non-coding followed by 4 coding exons) with the same translational start site as the primary transcript has also been reported [Author, personal observation].</p>
        <p><italic toggle="yes">De novo</italic> deletions involving the non-coding exons have been reported in several cases.</p>
        <p><bold>Pathogenic allelic variants.</bold> One nonsense and five frameshift pathogenic sequence variants have been reported to date, consistent with haploinsufficiency as a mechanism for <italic toggle="yes">MBD5</italic> haploinsufficiency. All pathogenic sequence variants occurred <italic toggle="yes">de novo</italic> (<xref ref-type="table" rid="mbd5-dis.T.selected_mbd5_pathogenic_vari">Table 2</xref>).</p>
        <table-wrap id="mbd5-dis.T.selected_mbd5_pathogenic_vari" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">MBD5</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.150delT</td>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr52HisfsTer31</td>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018328.4">NM_018328.4</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.440C&#x0003e;G</td>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser147Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.890_891delTA</td>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile297Thrfs</td>
              </tr>
              <tr>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.340_347delAAAAGCAT</td>
                <td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys114GlyfsTer35</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> MBD5 has two known isoforms, 1 (UniProtKB ID # <bold>Q9P267-1)</bold> and 2 (UniProtKB ID # <bold>Q9P267-2)</bold> [<xref ref-type="bibr" rid="mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</xref>].</p>
        <p>Isoform 1, the longer primary isoform, has 1448 amino acids encoded by exons 6-15 [<xref ref-type="bibr" rid="mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</xref>]. The protein has two conserved domains, a methyl-binding domain (MBD) and a proline-tryptophan-tryptophan-proline (PWWP) domain, both of which may be found in chromatin-associated proteins.</p>
        <p>Isoform 2 is encoded by exons 6-9, with intron 9 being retained, resulting in a protein of 851 amino acids that does not contain the PWWP domain.</p>
        <p>Isoforms 1 and 2 have amino acids 1-841 in common. In expression studies <xref ref-type="bibr" rid="mbd5-dis.REF.laget.2010.e11982">Laget et al [2010]</xref> showed that while isoform 1 is expressed in all tissues, it is highly expressed in brain and testis, and while isoform 2 is expressed in all tissues, it is highly expressed in brain and ovaries.</p>
        <p>MBD5 belongs to MBD family of proteins, which includes MBD1-6 and MeCp2 (encoded by <italic toggle="yes">MECP2</italic>, the gene involved in <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter">Rett syndrome</related-object>). The MBD proteins play key roles in regulating gene transcription. Most MBD proteins participate in chromatin remodeling and mediate gene silencing through their MBD motifs [<xref ref-type="bibr" rid="mbd5-dis.REF.tao.2014.279">Tao et al 2014</xref>]. MBD5, in contrast to other MBD proteins, has a deletion of nine amino acids in the first third of the domain and an insertion of six amino acids in the last third of the domain [<xref ref-type="bibr" rid="mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</xref>]. Using immunocytochemistry, <xref ref-type="bibr" rid="mbd5-dis.REF.camarena.2014.1003">Camarena et al [2014]</xref> showed that MBD5 localizes to non-heterochromatin regions of the nucleus, suggesting that MBD5 acts as a transcriptional activator.</p>
        <p>In addition to the MBD domain, this protein contains a PWWP domain (Pro-Trp-Trp-Pro motif), which consists of 100-150 amino acids found in numerous proteins involved in cell division, growth, and differentiation.</p>
        <p><bold>Abnormal gene product.</bold> Haploinsufficiency resulting from deletion or disruption of one <italic toggle="yes">MBD5</italic> allele is the cause of <italic toggle="yes">MBD5</italic> haploinsufficiency. In extensive expression studies using lymphoblastoid cell lines from persons with various <italic toggle="yes">MBD5</italic> deletions, <xref ref-type="bibr" rid="mbd5-dis.REF.talkowski.2011.551">Talkowski et al [2011]</xref> showed that <italic toggle="yes">MBD5</italic> mRNA expression levels were significantly reduced compared to levels in normal controls.</p>
        <p>Haploinsufficiency of <italic toggle="yes">MBD5</italic> results in dysregulation of other autism-associated genes, including <italic toggle="yes">UBE3A</italic> (<related-object link-type="booklink" source-id="gene" document-id="angelman" document-type="chapter">Angelman syndrome</related-object>), <italic toggle="yes">RAI1</italic> (<related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith-Magenis syndrome</related-object>)<italic toggle="yes">, TCF4</italic> (<related-object link-type="booklink" source-id="gene" document-id="pitt-hopkins" document-type="chapter">Pitt-Hopkins syndrome</related-object>)<italic toggle="yes">, MEF2C</italic> (5q14.3 deletion syndrome), and <italic toggle="yes">FMR1</italic> (<related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter"><italic toggle="yes">FMR1</italic>-related disorders</related-object>) [<xref ref-type="bibr" rid="mbd5-dis.REF.mullegama.2015a.7627">Mullegama et al 2015a</xref>]. Network database analyses utilizing databases such as Gene Mania and SFARI Gene show molecular connections between <italic toggle="yes">MBD5</italic> and several autism spectrum disorder-associated genes. The dysregulation of any of these genes can affect pathways and thus alter risks for phenotypes affecting sleep, language, and seizures present in persons with <italic toggle="yes">MBD5</italic> haploinsufficiency. Whether MBD5 directly or indirectly regulates some of these genes remains to be determined.</p>
      </sec>
      <sec id="mbd5-dis.References">
        <title>References</title>
        <sec id="mbd5-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mbd5-dis.Literature_Cited.reflist0">
            <ref id="mbd5-dis.REF.bonnet.2013.1457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali Khan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigouroux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;ri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lejczak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deemer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrieux</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moncla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devignes</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leheup</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonveaux</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Extended spectrum of MBD5 mutations in neurodevelopmental disorders.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>1457</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">23422940</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.camarena.2014.1003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Camarena</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abad</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <article-title>Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome.</article-title>
                <source>EMBO Mol Med.</source>
                <year>2014</year>
                <volume>6</volume>
                <fpage>1003</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">25001218</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.chung.2011.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stavropoulos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>424</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21271666</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.hodge.2014.368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodge</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillalamarri</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toler</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kearney</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanscom</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirmani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanson</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinner</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everman</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyd</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tapp</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keelean-Fuller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gusella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DuPont</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaubey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talkowski</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.</article-title>
                <source>Mol Psychiatry.</source>
                <year>2014</year>
                <volume>19</volume>
                <fpage>368</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">23587880</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.jaillard.2009.847">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaillard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e9;rard-Blanluet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delahaye</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabet</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aboura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benzacken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pipiras</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?</article-title>
                <source>J Med Genet.</source>
                <year>2009</year>
                <volume>46</volume>
                <fpage>847</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">18812405</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.laget.2010.e11982">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laget</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joulie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Masson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christians</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pradhan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defossez</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA.</article-title>
                <source>PLoS One.</source>
                <year>2010</year>
                <volume>5</volume>
                <fpage>e11982</fpage>
                <pub-id pub-id-type="pmid">20700456</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.motobayashi.2012.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Motobayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura-Tadaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inaba</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosho</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatake</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niimi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukushima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Neurodevelopmental features in 2q23.1 microdeletion syndrome: report of a new patient with intractable seizures and review of literature.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>861</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22407754</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.mullegama.2015a.7627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alaimo</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.</article-title>
                <source>Int J Mol Sci.</source>
                <year>2015a</year>
                <volume>16</volume>
                <fpage>7627</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">25853262</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.mullegama.2016.1376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2016</year>
                <volume>24</volume>
                <fpage>1376</fpage>
                <pub-id pub-id-type="pmid">27514998</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.mullegama.2014.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orellana</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bon</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halbach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repnikova</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brick</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosello</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aradhya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stavropoulos</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manickam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodge</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talkowski</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gusella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zonana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyatt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendoza-Londono</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <volume>22</volume>
                <fpage>57</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23632792</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.mullegama.2015b.781">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pugliesi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2015b</year>
                <volume>23</volume>
                <fpage>781</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25271084</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.noh.2012.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noh</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2012</year>
                <volume>55</volume>
                <fpage>59</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">22085995</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.shichiji.2013.850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shichiji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimojima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>A cryptic microdeletion including MBD5 occurring within the breakpoint of a reciprocal translocation between chromosomes 2 and 5 in a patient with developmental delay and obesity.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>850</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23494922</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.talkowski.2011.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Talkowski</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bon</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repnikova</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gastier-Foster</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrush</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kathiresan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruderfer</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanscom</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindgren</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astbury</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtenbelt</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ades</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fichera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innis</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholomew</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Allen</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parikh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyatt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gusella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>89</volume>
                <fpage>551</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">21981781</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.tan.2014.975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibert</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>If not Angelman, what is it? A review of Angelman-like syndromes.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2014</year>
                <volume>164A</volume>
                <fpage>975</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">24779060</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.tao.2014.279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice.</article-title>
                <source>Br J Haematol.</source>
                <year>2014</year>
                <volume>166</volume>
                <fpage>279</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">24750026</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.van_bon.2010.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bon</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koolen</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMullan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtenbelt</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ad&#x000e8;s</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moloney</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pramparo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Bernardina</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoccante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balottin</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piazza</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecile</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerci</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kets</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfundt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Brouwer</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veltman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antony</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reitano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luciano</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fichera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <article-title>The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2010</year>
                <volume>18</volume>
                <fpage>163</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19809484</pub-id>
              </element-citation>
            </ref>
            <ref id="mbd5-dis.REF.williams.2010.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullegama</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagli</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatchwell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2010</year>
                <volume>18</volume>
                <fpage>436</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19904302</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mbd5-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mbd5-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>27 October 2016 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>12 January 2016 (svm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
